Literature DB >> 22453918

The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial-mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1).

Zhiqiang Chen1, Daohai Zhang, Fei Yue, Minhua Zheng, Zaklina Kovacevic, Des R Richardson.   

Abstract

The epithelial-mesenchymal transition (EMT) is a key step for cancer cell migration, invasion, and metastasis. Transforming growth factor-β (TGF-β) regulates the EMT and the metastasis suppressor gene, N-myc downstream-regulated gene-1 (NDRG1), could play a role in regulating the TGF-β pathway. NDRG1 expression is markedly increased after chelator-mediated iron depletion via hypoxia-inducible factor 1α-dependent and independent pathways (Le, N. T. and Richardson, D. R. (2004) Blood 104, 2967-2975). Moreover, novel iron chelators show marked and selective anti-tumor activity and are a potential new class of anti-metabolites. Considering this, the current study investigated the relationship between NDRG1 and the EMT to examine if iron chelators can inhibit the EMT via NDRG1 up-regulation. We demonstrated that TGF-β induces the EMT in HT29 and DU145 cells. Further, the chelators, desferrioxamine (DFO) and di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), inhibited the TGF-β-induced EMT by maintaining E-cadherin and β-catenin, at the cell membrane. We then established stable clones with NDRG1 overexpression and knock-down in HT29 and DU145 cells. These data showed that NDRG1 overexpression maintained membrane E-cadherin and β-catenin and inhibited TGF-β-stimulated cell migration and invasion. Conversely, NDRG1 knock-down caused morphological changes from an epithelial- to fibroblastic-like phenotype and also increased migration and invasion, demonstrating NDRG1 knockdown induced the EMT and enhanced TGF-β effects. We also investigated the mechanisms involved and showed the TGF-β/SMAD and Wnt pathways were implicated in NDRG1 regulation of E-cadherin and β-catenin expression and translocation. This study demonstrates that chelators inhibit the TGF-β-induced EMT via a process consistent with NDRG1 up-regulation and elucidates the mechanism of their activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453918      PMCID: PMC3366822          DOI: 10.1074/jbc.M112.350470

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.

Authors:  V Ellenrieder; S F Hendler; W Boeck; T Seufferlein; A Menke; C Ruhland; G Adler; T M Gress
Journal:  Cancer Res       Date:  2001-05-15       Impact factor: 12.701

Review 2.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

3.  The Drg-1 gene suppresses tumor metastasis in prostate cancer.

Authors:  Sucharita Bandyopadhyay; Sudha K Pai; Steven C Gross; Shigeru Hirota; Sadahiro Hosobe; Kunio Miura; Ken Saito; Therese Commes; Sunao Hayashi; Misako Watabe; Kounosuke Watabe
Journal:  Cancer Res       Date:  2003-04-15       Impact factor: 12.701

4.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer.

Authors:  R J Guan; H L Ford; Y Fu; Y Li; L M Shaw; A B Pardee
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

5.  The involvement of hypoxia-inducible transcription factor-1-dependent pathway in nickel carcinogenesis.

Authors:  Konstantin Salnikow; Todd Davidson; Qunwei Zhang; Lung Chi Chen; Weichen Su; Max Costa
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

6.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation.

Authors:  Nghia T V Le; Des R Richardson
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

7.  The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.

Authors:  D Richardson; P Ponka; E Baker
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

8.  The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1.

Authors:  S X Liang; D R Richardson
Journal:  Carcinogenesis       Date:  2003-07-17       Impact factor: 4.944

9.  N-myc downregulated gene 1 is a phosphorylated protein in mast cells.

Authors:  Toshihiko Sugiki; Makoto Murakami; Yoshitaka Taketomi; Rei Kikuchi-Yanoshita; Ichiro Kudo
Journal:  Biol Pharm Bull       Date:  2004-05       Impact factor: 2.233

10.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors.

Authors:  P J Miettinen; R Ebner; A R Lopez; R Derynck
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

View more
  87 in total

1.  Di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT) overcomes multidrug resistance by a novel mechanism involving the hijacking of lysosomal P-glycoprotein (Pgp).

Authors:  Patric J Jansson; Tetsuo Yamagishi; Akanksha Arvind; Nicole Seebacher; Elaine Gutierrez; Alexandra Stacy; Sanaz Maleki; Danae Sharp; Sumit Sahni; Des R Richardson
Journal:  J Biol Chem       Date:  2015-02-26       Impact factor: 5.157

Review 2.  Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling.

Authors:  Sharleen V Menezes; Sumit Sahni; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2017-06-14       Impact factor: 5.157

3.  NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.

Authors:  Xiaojing Chang; Xiaoyang Xu; Jinguo Ma; Xiaoying Xue; Zhenhua Li; Peng Deng; Shuanglong Zhang; Yu Zhi; Jing Chen; Dongqiu Dai
Journal:  Mol Biol Rep       Date:  2014-07-02       Impact factor: 2.316

4.  Cx43 phosphorylation-mediated effects on ERK and Akt protect against ischemia reperfusion injury and alter the stability of the stress-inducible protein NDRG1.

Authors:  Joell L Solan; Lucrecia Márquez-Rosado; Paul D Lampe
Journal:  J Biol Chem       Date:  2019-06-12       Impact factor: 5.157

5.  The iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivo.

Authors:  Pengcheng Li; Xun Zheng; Kangquan Shou; Yahui Niu; Chao Jian; Yong Zhao; Wanrong Yi; Xiang Hu; Aixi Yu
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

6.  The metastasis suppressor NDRG1 down-regulates the epidermal growth factor receptor via a lysosomal mechanism by up-regulating mitogen-inducible gene 6.

Authors:  Sharleen V Menezes; Zaklina Kovacevic; Des R Richardson
Journal:  J Biol Chem       Date:  2019-01-24       Impact factor: 5.157

Review 7.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

8.  Long Noncoding RNA FENDRR Exhibits Antifibrotic Activity in Pulmonary Fibrosis.

Authors:  Chaoqun Huang; Yurong Liang; Xiangming Zeng; Xiaoyun Yang; Dao Xu; Xuxu Gou; Roshini Sathiaseelan; Lakmini Kumari Senavirathna; Pengcheng Wang; Lin Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2020-04       Impact factor: 6.914

9.  N-Myc Downstream-Regulated Gene 1 Restricts Hepatitis C Virus Propagation by Regulating Lipid Droplet Biogenesis and Viral Assembly.

Authors:  Cameron J Schweitzer; Fang Zhang; Audrey Boyer; Kristin Valdez; Maggie Cam; T Jake Liang
Journal:  J Virol       Date:  2018-01-02       Impact factor: 5.103

10.  Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis.

Authors:  Alan C Chen; Adriana Donovan; Renee Ned-Sykes; Nancy C Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.